Supira Medical

Supira Medical is a clinical-stage medical device company based in Los Gatos, California. The company specializes in developing next-generation percutaneous ventricular assist devices (pVADs) aimed at providing full hemodynamic support for high-risk patients undergoing interventional cardiac procedures and those experiencing cardiogenic shock. Supira Medical has raised significant funding, including a $120 million Series E financing round, to advance the development and commercialization of its innovative pVAD technology. The company's investigational pVAD system is currently undergoing clinical evaluation, with recent enrollment completed in the U.S. SUPPORT I Early Feasibility Study. This study assesses the safety and feasibility of the device in patients with complex coronary anatomy requiring mechanical circulatory support. Target customers for Supira Medical include hospitals and healthcare providers specializing in interventional and critical care cardiology. The company aims to address the unmet need for advanced ventricular support devices that can enhance clinical outcomes for high-risk cardiac patients.

• Employees 140
• Founded 2018
• Annual Revenue $11200000
• Total Funding $240599991